re: slt - valuation $1.06 to $1.45 current .054 so cheap, its a joke.
The HepA diagnostic is finished and ready for evaluation with these international firms. Its obvious they will do a deal and then what? it would then make CST look like a poor relo and hopfully the market wakes up out of this long sleep and gets with the program.
cellestis vs slt, page-14
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)